Search Results for keywords:"National Institute of Allergy and Infectious Diseases"

The National Institute of Allergy and Infectious Diseases is holding a closed meeting to review grant applications for the NIAID New Innovators Awards. The meeting will take place virtually on March 2-3, 2021, from 10:00 a.m. to 6:00 p.m. The discussions will include sensitive information, such as trade secrets and personal data, which is why the meeting is not open to the public. Jennifer H. Meyers, a Scientific Review Officer, can be contacted for more information.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 22, 2025, to discuss and evaluate contract proposals. This meeting will not be open to the public to protect confidential trade secrets, commercial information, and personal privacy. It will take place via video conference, and any inquiries can be directed to Anuja Mathew, Ph.D., at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases (NIAID) will hold a special meeting on February 23, 2021, to review and evaluate grant applications. This meeting will be conducted virtually and is closed to the public to protect confidential information related to trade secrets and personal privacy. Zhuqing (Charlie) Li, Ph.D., will serve as the Scientific Review Officer for this session. The meeting agenda will focus solely on research projects that do not involve clinical trials.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on January 30-31, 2025. The purpose of the meeting is to review and evaluate contract proposals and it will be conducted via video conferencing from their office in Rockville, MD. The meeting is closed to protect confidential trade secrets and personal information, according to federal guidelines. For additional information, Vishakha Sharma, Ph.D., is the contact person.

The Office of Research Integrity (ORI) has found that Dr. Yibin Lin engaged in research misconduct while working as a postdoctoral fellow at the University of Texas Health Science Center. Dr. Lin knowingly falsified and plagiarized data in several published papers and submitted manuscripts, which led to their retraction. He even created fictitious author names to disguise his actions. As a consequence, Dr. Lin agreed to a voluntary ten-year exclusion from participating in any federal government contracts and serving in any advisory capacities to the Public Health Service.

The National Institute of Allergy and Infectious Diseases is holding two closed meetings to review and evaluate contract proposals. These meetings will focus on reagents for immunologic analysis of non-mammalian and underrepresented mammalian models as part of the Small Business Innovation Research (SBIR) program. The first meeting for Phase I will occur on January 28, 2021, from 10:00 a.m. to 6:00 p.m., and the second meeting for Phase II will take place on January 29, 2021, from 10:00 a.m. to 2:00 p.m. Both meetings will be held virtually and closed to the public to protect confidential trade secrets and personal privacy.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting to discuss and evaluate contract proposals as part of a collaborative effort with the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). This meeting is set to take place virtually on February 2, 2021, from 11:00 a.m. to 4:00 p.m. The discussions will include confidential trade secrets or commercial information and personal details, so it will be closed to the public. Dr. Lynn Rust is the contact person for more information about this meeting.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 3-4, 2024, to review contract proposals related to vaccine adjuvant development. This meeting is closed to the public to protect sensitive information like trade secrets and personal privacy. The meeting will take place via video at the NIH facility in Rockville, MD. For further details, Michael M. Opata, Ph.D., is the contact person.

The National Institutes of Health (NIH) announced a closed meeting for the National Institute of Allergy and Infectious Diseases Special Emphasis Panel. This meeting, set for January 7, 2025, will focus on reviewing and evaluating contract proposals related to using artificial intelligence to enhance clinical microscopy for diagnosing infectious diseases. Due to confidential matters concerning trade secrets and personal privacy, the meeting will not be open to the public, and it will take place virtually at the NIH's Rockville, MD location.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting from April 14-16, 2025, to review and evaluate contract proposals related to the development of diagnostics for Mycoplasma genitalium infection. This meeting falls under specific federal regulations, which means it will not be open to the public to protect confidential and personal information. The discussions might involve trade secrets or sensitive commercial information. For more details, Dylan P. Flather, Ph.D., is the contact person available via email or phone.